Literature DB >> 28567391

Lobectomy: no port at all?

Yanping Ren1, Yuxin Jiao1, Xiangpeng Zheng1,2,3.   

Abstract

Year:  2017        PMID： 28567391      PMCID： PMC5440303          DOI： 10.21037/atm.2017.03.22

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  32 in total

1.  Stereotactic body radiotherapy for early-stage non-small-cell lung cancer: report of the ASTRO Emerging Technology Committee.

Authors:  Mark K Buyyounouski; Peter Balter; Brett Lewis; David J D'Ambrosio; Thomas J Dilling; Robert C Miller; Tracey Schefter; Wolfgang Tomé; Eleanor E R Harris; Robert A Price; Andre A Konski; Paul E Wallner
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-07-17       Impact factor: 7.038

2.  Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis.

Authors:  Sashendra Senthi; Frank J Lagerwaard; Cornelis J A Haasbeek; Ben J Slotman; Suresh Senan
Journal:  Lancet Oncol       Date:  2012-06-22       Impact factor: 41.316

Review 3.  European Organisation for Research and Treatment of Cancer recommendations for planning and delivery of high-dose, high-precision radiotherapy for lung cancer.

Authors:  Dirk De Ruysscher; Corinne Faivre-Finn; Ursula Nestle; Coen W Hurkmans; Cécile Le Péchoux; Allan Price; Suresh Senan
Journal:  J Clin Oncol       Date:  2010-11-15       Impact factor: 44.544

Review 4.  Stereotactic radiotherapy of primary lung cancer and other targets: results of consultant meeting of the International Atomic Energy Agency.

Authors:  Yasushi Nagata; Joern Wulf; Ingmar Lax; Robert Timmerman; Frank Zimmermann; Igor Stojkovski; Branislav Jeremic
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-03-01       Impact factor: 7.038

Review 5.  Radiation oncology in the era of precision medicine.

Authors:  Michael Baumann; Mechthild Krause; Jens Overgaard; Jürgen Debus; Søren M Bentzen; Juliane Daartz; Christian Richter; Daniel Zips; Thomas Bortfeld
Journal:  Nat Rev Cancer       Date:  2016-03-18       Impact factor: 60.716

6.  A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study.

Authors:  Jacob G Scott; Anders Berglund; Michael J Schell; Ivaylo Mihaylov; William J Fulp; Binglin Yue; Eric Welsh; Jimmy J Caudell; Kamran Ahmed; Tobin S Strom; Eric Mellon; Puja Venkat; Peter Johnstone; John Foekens; Jae Lee; Eduardo Moros; William S Dalton; Steven A Eschrich; Howard McLeod; Louis B Harrison; Javier F Torres-Roca
Journal:  Lancet Oncol       Date:  2016-12-18       Impact factor: 41.316

7.  Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.

Authors:  Joe Y Chang; Suresh Senan; Marinus A Paul; Reza J Mehran; Alexander V Louie; Peter Balter; Harry J M Groen; Stephen E McRae; Joachim Widder; Lei Feng; Ben E E M van den Borne; Mark F Munsell; Coen Hurkmans; Donald A Berry; Erik van Werkhoven; John J Kresl; Anne-Marie Dingemans; Omar Dawood; Cornelis J A Haasbeek; Larry S Carpenter; Katrien De Jaeger; Ritsuko Komaki; Ben J Slotman; Egbert F Smit; Jack A Roth
Journal:  Lancet Oncol       Date:  2015-05-13       Impact factor: 41.316

8.  Lobectomy versus stereotactic body radiotherapy in healthy patients with stage I lung cancer.

Authors:  Joshua E Rosen; Michelle C Salazar; Zuoheng Wang; James B Yu; Roy H Decker; Anthony W Kim; Frank C Detterbeck; Daniel J Boffa
Journal:  J Thorac Cardiovasc Surg       Date:  2016-04-07       Impact factor: 5.209

9.  Imaging features associated with disease progression after stereotactic ablative radiotherapy for stage I non-small-cell lung cancer.

Authors:  David B Shultz; Nicholas Trakul; Jonathan A Abelson; James D Murphy; Peter G Maxim; Quynh-Thu Le; Billy W Loo; Maximilian Diehn
Journal:  Clin Lung Cancer       Date:  2014-01-24       Impact factor: 4.785

10.  Assessing the Need for Adjuvant Chemotherapy After Stereotactic Body Radiation Therapy in Early-stage Non-small Cell Lung Carcinoma.

Authors:  Raphaël Jumeau; Houda Bahig; Édith Filion; Marie-Pierre Campeau; Louise Lambert; David Roberge; Andrei-Bogdan Gorgos; Toni Vu
Journal:  Cureus       Date:  2016-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.